NUCANA BIOMED LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for NUCANA BIOMED LIMITED.The latest application filed is for "combination therapy".

Company Profile

1.8.10

NUCANA BIOMED LIMITED - Edinburgh Scotland GB
NuCana Biomed Limited - Camberley N/A GB
NuCana BioMed Limited - London GB
NuCana BioMed Limited - GB GB
NuCana Biomed Limited - Edinburgh GB
Nucana Biomed Limited - Camberly Surrey GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy App 20190381084 - Griffith; Hugh	2019-12-19
Process for the preparation of gemcitabine-[phenyl(benzoxy-L-alaninyl)] phosphate Grant 9,834,577 - Dammalapati , et al. December 5, 2	2017-12-05
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20170312302 - McGuigan; Christopher ; et al.	2017-11-02
2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20170253629 - Griffith; Hugh ; et al.	2017-09-07
Methods Of Separating Gemcitabine-phosphate Diastereoisomers App 20170226147 - Griffith; Hugh	2017-08-10
Process For The Preparation Of Gemcitabine-[phenyl(benzoxy-l-alaninyl)] Phosphate App 20170166602 - Dammalapati; Venkata Lakshmi Narasimha Rao ; et al.	2017-06-15
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 9,655,915 - McGuigan , et al. May 23, 2	2017-05-23
Gemcitabine Prodrugs App 20170107246 - Griffith; Hugh ; et al.	2017-04-20
Formulation Comprising A Gemcitabine-prodrug App 20170095498 - Griffith; Hugh ; et al.	2017-04-06
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20160166596 - McGuigan; Christopher ; et al.	2016-06-16
Phosphoramidite derivatives of gemcitabine for use in the treatment of cancer Grant 9,321,798 - McGuigan April 26, 2	2016-04-26
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 9,221,866 - McGuigan , et al. December 29, 2	2015-12-29
Phosphoramidate Derivatives Of 5-fluoro-2'-deoxyuridine For Use In The Treatment Of Cancer App 20150183817 - McGuigan; Christopher ; et al.	2015-07-02
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 8,933,053 - McGuigan , et al. January 13, 2	2015-01-13
Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer Grant 8,263,575 - McGuigan , et al. September 11, 2	2012-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.